2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Testosterone Transdermal System Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-13W11594
Home | Market Reports | Health| Men s Health
Global Testosterone Transdermal System Market Research Report 2022
BUY CHAPTERS

Global Testosterone Transdermal System Market Research Report 2025

Code: QYRE-Auto-13W11594
Report
February 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Testosterone Transdermal System Market Size

The global market for Testosterone Transdermal System was valued at US$ 159 million in the year 2024 and is projected to reach a revised size of US$ 241 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Testosterone Transdermal System Market

Testosterone Transdermal System Market

Testosterone Transdermal is a testosterone replacement that acts like the natural sex hormone.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Testosterone Transdermal System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Transdermal System.
The Testosterone Transdermal System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Testosterone Transdermal System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Transdermal System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Testosterone Transdermal System Market Report

Report Metric Details
Report Name Testosterone Transdermal System Market
Accounted market size in year US$ 159 million
Forecasted market size in 2031 US$ 241 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Online Sales
  • Drugstore Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Allergan(Actavis), AbbVie, Endo International, Aytu BioPharma, Upsher-Smith Laboratories, Kyowa Hakko Kirin Co., Ltd., Besins Healthcare, Perrigo, TWi Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Testosterone Transdermal System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Testosterone Transdermal System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Testosterone Transdermal System Market growing?

Ans: The Testosterone Transdermal System Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Testosterone Transdermal System Market size in 2031?

Ans: The Testosterone Transdermal System Market size in 2031 will be US$ 241 million.

Who are the main players in the Testosterone Transdermal System Market report?

Ans: The main players in the Testosterone Transdermal System Market are Allergan(Actavis), AbbVie, Endo International, Aytu BioPharma, Upsher-Smith Laboratories, Kyowa Hakko Kirin Co., Ltd., Besins Healthcare, Perrigo, TWi Pharmaceuticals

What are the Application segmentation covered in the Testosterone Transdermal System Market report?

Ans: The Applications covered in the Testosterone Transdermal System Market report are Online Sales, Drugstore Sales

What are the Type segmentation covered in the Testosterone Transdermal System Market report?

Ans: The Types covered in the Testosterone Transdermal System Market report are Testosterone Patches, Testosterone Gels

Recommended Reports

Drug Delivery Systems

Hormonal Therapies

Urology and Andrology

1 Testosterone Transdermal System Market Overview
1.1 Product Definition
1.2 Testosterone Transdermal System by Type
1.2.1 Global Testosterone Transdermal System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Testosterone Patches
1.2.3 Testosterone Gels
1.3 Testosterone Transdermal System by Application
1.3.1 Global Testosterone Transdermal System Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Drugstore Sales
1.4 Global Testosterone Transdermal System Market Size Estimates and Forecasts
1.4.1 Global Testosterone Transdermal System Revenue 2020-2031
1.4.2 Global Testosterone Transdermal System Sales 2020-2031
1.4.3 Global Testosterone Transdermal System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Testosterone Transdermal System Market Competition by Manufacturers
2.1 Global Testosterone Transdermal System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Testosterone Transdermal System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Testosterone Transdermal System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Testosterone Transdermal System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Testosterone Transdermal System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Testosterone Transdermal System, Product Type & Application
2.7 Global Key Manufacturers of Testosterone Transdermal System, Date of Enter into This Industry
2.8 Global Testosterone Transdermal System Market Competitive Situation and Trends
2.8.1 Global Testosterone Transdermal System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Testosterone Transdermal System Players Market Share by Revenue
2.8.3 Global Testosterone Transdermal System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Testosterone Transdermal System Market Scenario by Region
3.1 Global Testosterone Transdermal System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Testosterone Transdermal System Sales by Region: 2020-2031
3.2.1 Global Testosterone Transdermal System Sales by Region: 2020-2025
3.2.2 Global Testosterone Transdermal System Sales by Region: 2026-2031
3.3 Global Testosterone Transdermal System Revenue by Region: 2020-2031
3.3.1 Global Testosterone Transdermal System Revenue by Region: 2020-2025
3.3.2 Global Testosterone Transdermal System Revenue by Region: 2026-2031
3.4 North America Testosterone Transdermal System Market Facts & Figures by Country
3.4.1 North America Testosterone Transdermal System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Testosterone Transdermal System Sales by Country (2020-2031)
3.4.3 North America Testosterone Transdermal System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Testosterone Transdermal System Market Facts & Figures by Country
3.5.1 Europe Testosterone Transdermal System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Testosterone Transdermal System Sales by Country (2020-2031)
3.5.3 Europe Testosterone Transdermal System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Testosterone Transdermal System Market Facts & Figures by Region
3.6.1 Asia Pacific Testosterone Transdermal System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Testosterone Transdermal System Sales by Region (2020-2031)
3.6.3 Asia Pacific Testosterone Transdermal System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Testosterone Transdermal System Market Facts & Figures by Country
3.7.1 Latin America Testosterone Transdermal System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Testosterone Transdermal System Sales by Country (2020-2031)
3.7.3 Latin America Testosterone Transdermal System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Testosterone Transdermal System Market Facts & Figures by Country
3.8.1 Middle East and Africa Testosterone Transdermal System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Testosterone Transdermal System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Testosterone Transdermal System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Testosterone Transdermal System Sales by Type (2020-2031)
4.1.1 Global Testosterone Transdermal System Sales by Type (2020-2025)
4.1.2 Global Testosterone Transdermal System Sales by Type (2026-2031)
4.1.3 Global Testosterone Transdermal System Sales Market Share by Type (2020-2031)
4.2 Global Testosterone Transdermal System Revenue by Type (2020-2031)
4.2.1 Global Testosterone Transdermal System Revenue by Type (2020-2025)
4.2.2 Global Testosterone Transdermal System Revenue by Type (2026-2031)
4.2.3 Global Testosterone Transdermal System Revenue Market Share by Type (2020-2031)
4.3 Global Testosterone Transdermal System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Testosterone Transdermal System Sales by Application (2020-2031)
5.1.1 Global Testosterone Transdermal System Sales by Application (2020-2025)
5.1.2 Global Testosterone Transdermal System Sales by Application (2026-2031)
5.1.3 Global Testosterone Transdermal System Sales Market Share by Application (2020-2031)
5.2 Global Testosterone Transdermal System Revenue by Application (2020-2031)
5.2.1 Global Testosterone Transdermal System Revenue by Application (2020-2025)
5.2.2 Global Testosterone Transdermal System Revenue by Application (2026-2031)
5.2.3 Global Testosterone Transdermal System Revenue Market Share by Application (2020-2031)
5.3 Global Testosterone Transdermal System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Allergan(Actavis)
6.1.1 Allergan(Actavis) Company Information
6.1.2 Allergan(Actavis) Description and Business Overview
6.1.3 Allergan(Actavis) Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Allergan(Actavis) Testosterone Transdermal System Product Portfolio
6.1.5 Allergan(Actavis) Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AbbVie Testosterone Transdermal System Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Company Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Endo International Testosterone Transdermal System Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Aytu BioPharma
6.4.1 Aytu BioPharma Company Information
6.4.2 Aytu BioPharma Description and Business Overview
6.4.3 Aytu BioPharma Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Aytu BioPharma Testosterone Transdermal System Product Portfolio
6.4.5 Aytu BioPharma Recent Developments/Updates
6.5 Upsher-Smith Laboratories
6.5.1 Upsher-Smith Laboratories Company Information
6.5.2 Upsher-Smith Laboratories Description and Business Overview
6.5.3 Upsher-Smith Laboratories Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Upsher-Smith Laboratories Testosterone Transdermal System Product Portfolio
6.5.5 Upsher-Smith Laboratories Recent Developments/Updates
6.6 Kyowa Hakko Kirin Co., Ltd.
6.6.1 Kyowa Hakko Kirin Co., Ltd. Company Information
6.6.2 Kyowa Hakko Kirin Co., Ltd. Description and Business Overview
6.6.3 Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Product Portfolio
6.6.5 Kyowa Hakko Kirin Co., Ltd. Recent Developments/Updates
6.7 Besins Healthcare
6.7.1 Besins Healthcare Company Information
6.7.2 Besins Healthcare Description and Business Overview
6.7.3 Besins Healthcare Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Besins Healthcare Testosterone Transdermal System Product Portfolio
6.7.5 Besins Healthcare Recent Developments/Updates
6.8 Perrigo
6.8.1 Perrigo Company Information
6.8.2 Perrigo Description and Business Overview
6.8.3 Perrigo Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Perrigo Testosterone Transdermal System Product Portfolio
6.8.5 Perrigo Recent Developments/Updates
6.9 TWi Pharmaceuticals
6.9.1 TWi Pharmaceuticals Company Information
6.9.2 TWi Pharmaceuticals Description and Business Overview
6.9.3 TWi Pharmaceuticals Testosterone Transdermal System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TWi Pharmaceuticals Testosterone Transdermal System Product Portfolio
6.9.5 TWi Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Testosterone Transdermal System Industry Chain Analysis
7.2 Testosterone Transdermal System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Testosterone Transdermal System Production Mode & Process Analysis
7.4 Testosterone Transdermal System Sales and Marketing
7.4.1 Testosterone Transdermal System Sales Channels
7.4.2 Testosterone Transdermal System Distributors
7.5 Testosterone Transdermal System Customer Analysis
8 Testosterone Transdermal System Market Dynamics
8.1 Testosterone Transdermal System Industry Trends
8.2 Testosterone Transdermal System Market Drivers
8.3 Testosterone Transdermal System Market Challenges
8.4 Testosterone Transdermal System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Testosterone Transdermal System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Testosterone Transdermal System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Testosterone Transdermal System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Testosterone Transdermal System Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Testosterone Transdermal System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Testosterone Transdermal System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Testosterone Transdermal System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Testosterone Transdermal System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Testosterone Transdermal System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Testosterone Transdermal System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Testosterone Transdermal System, Product Type & Application
 Table 12. Global Key Manufacturers of Testosterone Transdermal System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Testosterone Transdermal System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Transdermal System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Testosterone Transdermal System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Testosterone Transdermal System Sales by Region (2020-2025) & (K Units)
 Table 18. Global Testosterone Transdermal System Sales Market Share by Region (2020-2025)
 Table 19. Global Testosterone Transdermal System Sales by Region (2026-2031) & (K Units)
 Table 20. Global Testosterone Transdermal System Sales Market Share by Region (2026-2031)
 Table 21. Global Testosterone Transdermal System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Testosterone Transdermal System Revenue Market Share by Region (2020-2025)
 Table 23. Global Testosterone Transdermal System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Testosterone Transdermal System Revenue Market Share by Region (2026-2031)
 Table 25. North America Testosterone Transdermal System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Testosterone Transdermal System Sales by Country (2020-2025) & (K Units)
 Table 27. North America Testosterone Transdermal System Sales by Country (2026-2031) & (K Units)
 Table 28. North America Testosterone Transdermal System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Testosterone Transdermal System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Testosterone Transdermal System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Testosterone Transdermal System Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Testosterone Transdermal System Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Testosterone Transdermal System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Testosterone Transdermal System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Testosterone Transdermal System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Testosterone Transdermal System Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Testosterone Transdermal System Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Testosterone Transdermal System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Testosterone Transdermal System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Testosterone Transdermal System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Testosterone Transdermal System Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Testosterone Transdermal System Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Testosterone Transdermal System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Testosterone Transdermal System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Testosterone Transdermal System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Testosterone Transdermal System Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Testosterone Transdermal System Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Testosterone Transdermal System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Testosterone Transdermal System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Testosterone Transdermal System Sales (K Units) by Type (2020-2025)
 Table 51. Global Testosterone Transdermal System Sales (K Units) by Type (2026-2031)
 Table 52. Global Testosterone Transdermal System Sales Market Share by Type (2020-2025)
 Table 53. Global Testosterone Transdermal System Sales Market Share by Type (2026-2031)
 Table 54. Global Testosterone Transdermal System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Testosterone Transdermal System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Testosterone Transdermal System Revenue Market Share by Type (2020-2025)
 Table 57. Global Testosterone Transdermal System Revenue Market Share by Type (2026-2031)
 Table 58. Global Testosterone Transdermal System Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Testosterone Transdermal System Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Testosterone Transdermal System Sales (K Units) by Application (2020-2025)
 Table 61. Global Testosterone Transdermal System Sales (K Units) by Application (2026-2031)
 Table 62. Global Testosterone Transdermal System Sales Market Share by Application (2020-2025)
 Table 63. Global Testosterone Transdermal System Sales Market Share by Application (2026-2031)
 Table 64. Global Testosterone Transdermal System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Testosterone Transdermal System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Testosterone Transdermal System Revenue Market Share by Application (2020-2025)
 Table 67. Global Testosterone Transdermal System Revenue Market Share by Application (2026-2031)
 Table 68. Global Testosterone Transdermal System Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Testosterone Transdermal System Price (US$/Unit) by Application (2026-2031)
 Table 70. Allergan(Actavis) Company Information
 Table 71. Allergan(Actavis) Description and Business Overview
 Table 72. Allergan(Actavis) Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Allergan(Actavis) Testosterone Transdermal System Product
 Table 74. Allergan(Actavis) Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AbbVie Testosterone Transdermal System Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. Endo International Company Information
 Table 81. Endo International Description and Business Overview
 Table 82. Endo International Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Endo International Testosterone Transdermal System Product
 Table 84. Endo International Recent Developments/Updates
 Table 85. Aytu BioPharma Company Information
 Table 86. Aytu BioPharma Description and Business Overview
 Table 87. Aytu BioPharma Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Aytu BioPharma Testosterone Transdermal System Product
 Table 89. Aytu BioPharma Recent Developments/Updates
 Table 90. Upsher-Smith Laboratories Company Information
 Table 91. Upsher-Smith Laboratories Description and Business Overview
 Table 92. Upsher-Smith Laboratories Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Upsher-Smith Laboratories Testosterone Transdermal System Product
 Table 94. Upsher-Smith Laboratories Recent Developments/Updates
 Table 95. Kyowa Hakko Kirin Co., Ltd. Company Information
 Table 96. Kyowa Hakko Kirin Co., Ltd. Description and Business Overview
 Table 97. Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Kyowa Hakko Kirin Co., Ltd. Testosterone Transdermal System Product
 Table 99. Kyowa Hakko Kirin Co., Ltd. Recent Developments/Updates
 Table 100. Besins Healthcare Company Information
 Table 101. Besins Healthcare Description and Business Overview
 Table 102. Besins Healthcare Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Besins Healthcare Testosterone Transdermal System Product
 Table 104. Besins Healthcare Recent Developments/Updates
 Table 105. Perrigo Company Information
 Table 106. Perrigo Description and Business Overview
 Table 107. Perrigo Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Perrigo Testosterone Transdermal System Product
 Table 109. Perrigo Recent Developments/Updates
 Table 110. TWi Pharmaceuticals Company Information
 Table 111. TWi Pharmaceuticals Description and Business Overview
 Table 112. TWi Pharmaceuticals Testosterone Transdermal System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. TWi Pharmaceuticals Testosterone Transdermal System Product
 Table 114. TWi Pharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Testosterone Transdermal System Distributors List
 Table 118. Testosterone Transdermal System Customers List
 Table 119. Testosterone Transdermal System Market Trends
 Table 120. Testosterone Transdermal System Market Drivers
 Table 121. Testosterone Transdermal System Market Challenges
 Table 122. Testosterone Transdermal System Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Testosterone Transdermal System
 Figure 2. Global Testosterone Transdermal System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Testosterone Transdermal System Market Share by Type: 2024 & 2031
 Figure 4. Testosterone Patches Product Picture
 Figure 5. Testosterone Gels Product Picture
 Figure 6. Global Testosterone Transdermal System Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Testosterone Transdermal System Market Share by Application: 2024 & 2031
 Figure 8. Online Sales
 Figure 9. Drugstore Sales
 Figure 10. Global Testosterone Transdermal System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Testosterone Transdermal System Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Testosterone Transdermal System Sales (2020-2031) & (K Units)
 Figure 13. Global Testosterone Transdermal System Average Price (US$/Unit) & (2020-2031)
 Figure 14. Testosterone Transdermal System Report Years Considered
 Figure 15. Testosterone Transdermal System Sales Share by Manufacturers in 2024
 Figure 16. Global Testosterone Transdermal System Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Testosterone Transdermal System Players: Market Share by Revenue in Testosterone Transdermal System in 2024
 Figure 18. Testosterone Transdermal System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Testosterone Transdermal System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Testosterone Transdermal System Sales Market Share by Country (2020-2031)
 Figure 21. North America Testosterone Transdermal System Revenue Market Share by Country (2020-2031)
 Figure 22. United States Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Testosterone Transdermal System Sales Market Share by Country (2020-2031)
 Figure 25. Europe Testosterone Transdermal System Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Testosterone Transdermal System Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Testosterone Transdermal System Revenue Market Share by Region (2020-2031)
 Figure 33. China Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Testosterone Transdermal System Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Testosterone Transdermal System Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Testosterone Transdermal System Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Testosterone Transdermal System Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Testosterone Transdermal System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Testosterone Transdermal System by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Testosterone Transdermal System by Type (2020-2031)
 Figure 54. Global Testosterone Transdermal System Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Testosterone Transdermal System by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Testosterone Transdermal System by Application (2020-2031)
 Figure 57. Global Testosterone Transdermal System Price (US$/Unit) by Application (2020-2031)
 Figure 58. Testosterone Transdermal System Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Testicular Cancer Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26B6701
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Biomarker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12M6232
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Benign Prostatic Hyperplasia Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39G5907
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7B2445
Mon Sep 08 00:00:00 UTC 2025

Add to Cart